Cerebral Autoregulation and Delirium Study

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorUniversity Health Network, Toronto

About this trial

Approximately one in four elderly patients develops postoperative delirium (POD) after cardiac surgery. POD is associated with prolonged hospitalization, increased mortality, and higher health care costs. While patient-related risk factors are often difficult to modify, surgery- and anesthesia-related factors may be optimized to reduce the incidence of POD. One potentially modifiable factor is intraoperative blood pressure management. Current practice commonly relies on standardized blood pressure targets during cardiac surgery; however, this "one-size-fits-all" approach may not account for individual variability in cerebral perfusion requirements. This study proposes a personalized blood pressure management strategy based on real-time monitoring of cerebral autoregulation, with the goal of maintaining optimal cerebral perfusion and protecting the brain from both hypo- and hyper-perfusion

Eligibility criteria

Qualifiers

None

Disqualifiers

Patients with symptomatic cerebrovascular disease.

History of delirium.

Major neurocognitive impairment (e.g., dementia or Mini-Mental State Examination score < 10).

Schizophrenia.

Trial design

Treatments tested in this trial

  • Mespere NeuroOs (Mespere Life Sciences) monitor

Treatment groups

60 Participants
are divided into 2 treatment groups

Locations

This trial has no locations